Cargando…
Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro
Glioblastoma (GBM) is the most common primary brain tumor. Tumor hypoxia is a pivotal factor responsible for the progression of this malignant glioma, and its resistance to radiation and chemotherapy. Thus, improved tumor tissue oxygenation may promote greater sensitivity to anticancer treatment. Pr...
Autores principales: | Zembrzuska, Katarzyna, Ostrowski, Robert P., Matyja, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448092/ https://www.ncbi.nlm.nih.gov/pubmed/30896865 http://dx.doi.org/10.3892/or.2019.7064 |
Ejemplares similares
-
Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours
por: Stępień, Katarzyna, et al.
Publicado: (2016) -
The efficacy of hyperbaric oxygen in hemorrhagic stroke: experimental and clinical implications
por: Ostrowski, Robert P., et al.
Publicado: (2017) -
Hyperbaric oxygen modalities are differentially effective in distinct brain ischemia models
por: Ostrowski, Robert P., et al.
Publicado: (2016) -
Proteasome and Neuroprotective Effect of Hyperbaric Oxygen Preconditioning in Experimental Global Cerebral Ischemia in Rats
por: Ostrowski, Robert P., et al.
Publicado: (2022) -
Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice
por: Lu, Zhaohui, et al.
Publicado: (2016)